Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Meya

Showing results (31-40 of 260) with videos related to

Pageof 26
Sort By:
Infection and Immunity|March 3, 2025
The hypervirulent Type-1/Type-17 phenotype of <i>Cryptococcus neoformans</i> clinical isolates is specific to A/J miceMinna Ding, Katrina M Jackson, Madeline Harris-Gordon, et al.
Journal of Fungi (Basel, Switzerland)|May 26, 2019
HIV-Associated Cryptococcal Immune Reconstitution Inflammatory Syndrome Is Associated with Aberrant T Cell Function and Increased Cytokine ResponsesDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Medical Mycology|December 22, 2025
Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal culturesAndrew Akampurira, Thomas C McHale, Tony Luggya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2018
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in UgandaElizabeth Nalintya, David B Meya, Sarah Lofgren, et al.
Plos Neglected Tropical Diseases|April 30, 2020
Mycetoma in Uganda: A neglected tropical diseaseRichard Kwizera, Felix Bongomin, David B Meya, et al.
PLOS Global Public Health|October 18, 2023
Clinical characteristics and morbidity among hospitalized adults with advanced HIV disease in Uganda during 'test and treat' eraLillian Tugume, Fred C Semitala, Darius Owachi, et al.
Plos One|August 1, 2014
Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100Richard Kwizera, Joyce Nguna, Agnes Kiragga, et al.
Medical Mycology|January 13, 2022
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countriesRadha Rajasingham, Elizabeth Nalintya, Dennis M Israelski, et al.
Medical Mycology Case Reports|April 15, 2015
Gastrointestinal cryptococcoma - Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS?Abdu K Musubire, David B Meya, Robert Lukande, et al.
Plos One|June 2, 2026
Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screeningAlexandra Poeschla, Abduljewad Wele, Elizabeth Nalintya, et al.
Pageof 26

Showing results (31-40 of 260) with videos related to

Sort By:
Pageof 26
Infection and Immunity|March 3, 2025
The hypervirulent Type-1/Type-17 phenotype of <i>Cryptococcus neoformans</i> clinical isolates is specific to A/J miceMinna Ding, Katrina M Jackson, Madeline Harris-Gordon, et al.
Journal of Fungi (Basel, Switzerland)|May 26, 2019
HIV-Associated Cryptococcal Immune Reconstitution Inflammatory Syndrome Is Associated with Aberrant T Cell Function and Increased Cytokine ResponsesDavid B Meya, Samuel Okurut, Godfrey Zziwa, et al.
Medical Mycology|December 22, 2025
Analytical validation: Comparison of two laboratory-based methods for CSF quantitative cryptococcal culturesAndrew Akampurira, Thomas C McHale, Tony Luggya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2018
A Prospective Evaluation of a Multisite Cryptococcal Screening and Treatment Program in HIV Clinics in UgandaElizabeth Nalintya, David B Meya, Sarah Lofgren, et al.
Plos Neglected Tropical Diseases|April 30, 2020
Mycetoma in Uganda: A neglected tropical diseaseRichard Kwizera, Felix Bongomin, David B Meya, et al.
PLOS Global Public Health|October 18, 2023
Clinical characteristics and morbidity among hospitalized adults with advanced HIV disease in Uganda during 'test and treat' eraLillian Tugume, Fred C Semitala, Darius Owachi, et al.
Plos One|August 1, 2014
Performance of cryptococcal antigen lateral flow assay using saliva in Ugandans with CD4 <100Richard Kwizera, Joyce Nguna, Agnes Kiragga, et al.
Medical Mycology|January 13, 2022
Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countriesRadha Rajasingham, Elizabeth Nalintya, Dennis M Israelski, et al.
Medical Mycology Case Reports|April 15, 2015
Gastrointestinal cryptococcoma - Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS?Abdu K Musubire, David B Meya, Robert Lukande, et al.
Plos One|June 2, 2026
Change in plasma cryptococcal antigen titers in Uganda among outpatients with advanced HIV disease from 2017 to 2022 with rollout of national cryptococcal screeningAlexandra Poeschla, Abduljewad Wele, Elizabeth Nalintya, et al.
Pageof 26